NCT07666607

Brief Summary

This study focuses on the specificity of thermosensitive targets in populations with hypertension in cold regions, identifies core targets through transcriptome sequencing and clinical validation, and clarifies the regulatory mechanism of moderate-intensity aerobic exercise through a prospective cohort study, providing scientific basis for precise prevention and treatment of hypertension in cold regions and personalized exercise intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 24, 2026

Completed
Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

1.2 years

First QC Date

June 13, 2026

Last Update Submit

June 18, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • blood pressure (BP)

    Systolic blood pressure, unit: mmHg Diastolic blood pressure, unit: mmHg Mean arterial pressure, unit: mmHg

    December 28, 2025

  • heart rate variability (HRV)

    Low Frequency,Unit: nu High Frequency ,Unit: nu Low Frequency / High Frequency ratio Root Mean Square of Successive Differences,Unit: ms Percentage of successive NN intervals differing by more than 50 ms,Unit: % Standard Deviation of all Normal-to-Normal RR intervals,Unit: ms

    28 December 2025

  • markers of the sympathetic nervous system (SNS)

    Epinephrine, unit: ng/L Norepinephrine, unit: ng/L

    December 28, 2025

  • mRNA expression of genes

    Unit: relative expression level

    December 28, 2025

Interventions

Patients with essential hypertension in cold regions who met the inclusion criteria were prospectively recruited and divided into an exercise exposure group and a non-exercise control group based on their willingness to accept and adhere to the exercise protocol developed for this study, with a follow-up period of 16 weeks. At baseline and the end of follow-up, we measured the expression of core thermosensitive targets, blood pressure (BP), heart rate variability (HRV), as well as the levels of sympathetic neurotransmitters and indicators of the renin-angiotensin-aldosterone system (RAAS), and compared the changes in these indicators between the two groups.

Eligibility Criteria

Age60 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Hypertensive population

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Harbin Sport University

Harbin, Heilongjiang, 150008, China

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
16 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Ph.D.

Study Record Dates

First Submitted

June 13, 2026

First Posted

June 24, 2026

Study Start

October 4, 2024

Primary Completion

December 28, 2025

Study Completion

December 28, 2025

Last Updated

June 24, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations